Implementation Science Center in Cancer Control Equity: A Competitive Revision to Accelerate COVID Testing in Vulnerable Communities
癌症控制公平实施科学中心:加速弱势社区新冠病毒检测的竞争性修订
基本信息
- 批准号:10228389
- 负责人:
- 金额:$ 343.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressCOVID-19Cancer CenterCancer ControlCollaborationsCommunicable DiseasesCommunicationCommunitiesContact TracingDiagnostic testsEthicsEvidence based practiceFutureHomelessnessHot SpotHousingHumanHuman immunodeficiency virus testIndividualInfrastructureInterruptionLaboratoriesLimited English ProficiencyLinguisticsMassachusettsMedicalMethodsMonitorNeighborhood Health CenterParticipantPatientsPhasePilot ProjectsPopulationPositioning AttributePreventionResearchResearch DesignResearch PersonnelResourcesSeriesSubstance Use DisorderTestingTimeUnderserved PopulationVulnerable PopulationsWagesWorkbasecommunity partnershipcoronavirus diseasedesignexperiencehigh riskimplementation scienceinnovationlensmemberoutreachpatient orientedprospectivesocial
项目摘要
Abstract
This competitive revision submitted to the RADx-UP Initiative (NOT-20-121) aims to extend the infrastructure of
our P50 Implementation Science Center for Cancer Control Equity (ISCCCE) to accelerate COVID testing in 9
hotspot communities in MA. ISCCCE is a strong partnership with the Massachusetts League of Community
Health Centers, in which we co-design studies to increase implementation of evidence-based practices
focused on equity. Together we are extremely well-positioned to extend our community-engaged efforts to
COVID-19 testing, and to build an infrastructure that will support future COVID-related mitigation and
prevention efforts in the vulnerable communities that our community health centers (CHCs) serve. This project
will include 6 community health center- community partnerships in nine vulnerable communities that continue
to be COVID hot spots. These communities collectively have 1.3 million residents. Partner CHCs currently
focus on COVID-19 testing for diagnostic purposes in symptomatic individuals, with limited outreach testing in
high-risk communities. This project will expand the scope of testing to include prospective surveillance
activities using dedicated testing and outreach teams. Accelerated testing efforts will be focused on CHC
patients and community members who have significant social and medical vulnerabilities to COVID, per the
NOSI, including those living in congregate housing, people experiencing homelessness, those with substance
use disorders, low wage essential workers, and those with limited English proficiency. The partnership is well-
integrated into the State’s testing and contact tracing strategy, and well-positioned to leverage those
resources. We draw on our strongly community-engaged, equity-focused approach to implementation, and on
Mass League’s extensive experience in HIV testing and contact tracing.
We will use an interrupted time series design to evaluate the impact of the enhanced outreach efforts on
testing rates overall and on priority populations in the context of different phases of re-opening and restrictions.
We will also use an exploratory sequential mixed methods approach to conduct a series of community-
engaged pilot studies to address key barriers to testing and different approaches to return of results. Our
Human Participant Research Unit, co-led by academic and community-based investigators, will guide the
partnership’s work through an ethics and equity lens. We will support the CHC-community partnerships
through our Testing Capacity and Innovation Team, which will provide infectious disease expertise and
technical guidance on COVID testing. Our Community Communications Team will use educational and
communication design strategies to develop culturally and linguistically appropriate materials to support the
testing activities.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Dargon-Hart其他文献
Susan Dargon-Hart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Dargon-Hart', 18)}}的其他基金
The Implementation Science Center for Cancer Control Equity
癌症控制公平实施科学中心
- 批准号:
10540459 - 财政年份:2020
- 资助金额:
$ 343.23万 - 项目类别:
"Tu Bienestar (Your Wellness): Health Home for At-Risk Latinas"
“Tu Bienestar(您的健康):拉丁裔高危人群的健康之家”
- 批准号:
8725632 - 财政年份:2013
- 资助金额:
$ 343.23万 - 项目类别:
"Tu Bienestar (Your Wellness): Health Home for At-Risk Latinas"
“Tu Bienestar(您的健康):拉丁裔高危人群的健康之家”
- 批准号:
8716148 - 财政年份:2013
- 资助金额:
$ 343.23万 - 项目类别:
Grove Hall Getting Healthier (GH)2 Supplemental Rapid HIV Testing
格罗夫霍尔变得更健康 (GH)2 补充快速 HIV 检测
- 批准号:
8324103 - 财政年份:2008
- 资助金额:
$ 343.23万 - 项目类别:
Grove Hall Getting Healthier (GH)2 Supplemental Rapid HIV Testing
格罗夫霍尔变得更健康 (GH)2 补充快速 HIV 检测
- 批准号:
8543159 - 财政年份:2008
- 资助金额:
$ 343.23万 - 项目类别:
相似国自然基金
CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
- 批准号:82370569
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
COVID-19疫情对我国儿童生长发育影响的异质性研究
- 批准号:42371429
- 批准年份:2023
- 资助金额:52.00 万元
- 项目类别:面上项目
传染病模型的稳态切换过程研究及其在治疗COVID-19中的应用
- 批准号:LQ23A010016
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
“湿漫膜原”视角下研究加味达原饮重塑COVID-19“免疫炎症稳态”的分子机制:TLR4介导IRF3/NF-κB通路串扰
- 批准号:82374291
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
COVID-19中线粒体囊泡抑制CD8+T细胞记忆分化的机制研究
- 批准号:82300018
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
COVID-19疫情爆发后武汉地区儿童副流感病毒3型的流行趋势和进化规律研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于 GDF15-IL6 信号轴探究扶正解毒方逆转血管内皮衰老治疗COVID-19的作用与机制
- 批准号:82374392
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
多维不平稳和长记忆性的复杂整值时间序列的建模及其在Covid-19研究中的应用
- 批准号:12301358
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
COVID-19疫苗同源、异源加强剂次细胞免疫与体液免疫效应的前瞻性队列研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:10.0 万元
- 项目类别:省市级项目
基于人源细胞3D培养和精密肺切片技术探讨慢阻肺患者COVID-19易感机制研究
- 批准号:LY23H190003
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
COVID-19とデジタルネイティブ世代-多言語による語りの収集と分析
COVID-19 和数字原生代 - 多语言叙述的收集和分析
- 批准号:
23K21932 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
COVID-19関連失業者の心理的ストレスと包括的支援ー環境と個人へのアプローチ
对与 COVID-19 相关的失业工人的心理压力和综合支持:针对环境和个人的方法
- 批准号:
23K20767 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
COVID-19後遺症と中枢神経内炎症の関連性: PETイメージングによる探索的研究
COVID-19 后遗症与中枢神经系统炎症之间的关系:使用 PET 成像的探索性研究
- 批准号:
24K02387 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
COVID-19後遺症のリスク低減を目指したAIによるデータ駆動型予測システムの構築
使用 AI 构建数据驱动的预测系统,以降低 COVID-19 后遗症的风险
- 批准号:
24K13321 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
COVID-19パンデミックが自殺率の推移に及ぼした影響の解明
阐明 COVID-19 大流行对自杀率趋势的影响
- 批准号:
24K13500 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
COVID-19に学ぶ高齢者居住施設の建築計画 体験語りの環境把握と多分野協働の試み
老年生活设施的建筑规划从 COVID-19 中学习:通过经验故事了解环境并尝试多学科合作
- 批准号:
24K07849 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
森林浴の癒やし効果を活用した観光資源開発支援:COVID-19後に楽しく観光するために
利用森林浴的治愈效果支持旅游资源开发:为了在COVID-19之后享受愉快的观光
- 批准号:
23K28338 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-COVID-19 Multicultural Community Building in Japan: Enhancing Risk Communication and Resilience among Foreign Residents
COVID-19 后日本的多元文化社区建设:加强外国居民的风险沟通和抵御能力
- 批准号:
24K15447 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
COVID-19における細胞外小胞の臨床的意義と現場実装に向けた新規検出技術の基盤確立
细胞外囊泡在COVID-19中的临床意义及为现场实施建立新的检测技术基础
- 批准号:
23K27699 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
COVID-19, health and labour market marginalisation
COVID-19、健康和劳动力市场边缘化
- 批准号:
DP230102184 - 财政年份:2024
- 资助金额:
$ 343.23万 - 项目类别:
Discovery Projects